Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial.

Autor:	Nofal A; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Nofal H; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; Biotechnology Program, School of Sciences and Engineering, the American University in Cairo, Cairo, Egypt. Electronic address: hnofal@medicine.zu.edu.eg., Alwirshiffani E; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; Faculty of Medicine, University of Tripoli, Tripoli, Libya., ElGhareeb MI; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Jazyk:	angličtina
Zdroj:	Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Nov; Vol. 89 (5), pp. 1051-1052. Date of Electronic Publication: 2023 Jul 06.
DOI:	10.1016/j.jaad.2023.06.042
Abstrakt:	Competing Interests: Conflicts of interest None disclosed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect